Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 8/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15588225 | 0.86 | EPHX2 (0.34) | EPHX2MAPK8MAPK10MAPK14TP53 | |
| SCHEMBL6934192 | 0.86 | EPHX2 (0.36) | EPHX2MAPK8MAPK10TP53ADORA3 | |
| SCHEMBL6827910 | 0.84 | TP53 (0.47) | EPHX2TP53GAA | |
| SCHEMBL108442 | 0.84 | TP53 (0.47) | EPHX2TP53GAA | |
| SCHEMBL13339539 | 0.84 | TP53 (0.47) | EPHX2TP53GAA | |
| SCHEMBL10353794 | 0.83 | KMT2A (0.38) | TP53 | |
| SCHEMBL18528969 | 0.83 | — | — | |
| SCHEMBL9605412 | 0.81 | TP53 (0.48) | TP53GAA | |
| SCHEMBL19774486 | 0.80 | EPHX2 (0.33) | EPHX2MAPK8MAPK10TP53ADORA3 | |
| SCHEMBL13083485 | 0.79 | PLG (0.35) | EPHX2MAPK8MAPK10MAPK14ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2369924-A1 | NITROOXY CYCLOALKANE DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2011-10-05 | — | — | EP | disclosed |
| WO-2010062415-A1 | NITROOXY CYCLOALKANE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2010-06-03 | — | — | WO | disclosed |